XGEVA
Google image searchProduct monograph
Active ingredient
denosumab, 120 MG/1.7 ML
DIN: 02368153
Dosage form(s): SOLUTION
Route(s) of administration: SUBCUTANEOUS
Description: SINGLE-USE VIAL. FOR S.C. USE ONLY. PRESERVATIVE-FREE.
Schedule: Prescription / Schedule D
Company: AMGEN CANADA INC
Date: 06-JUN-2011
ATC:
- M05 — DRUGS FOR TREATMENT OF BONE DISEASES (ATC, ATC/DDD, )
- M05B — DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION (ATC, ATC/DDD)
- M05BX — Other drugs affecting bone structure and mineralization (ATC, ATC/DDD)
- M05BX04 — DENOSUMAB (ATC/DDD)
Reference brand drug: Prolia, Xgeva
